You are not logged in (login)
Home > Research > Areas > Infectious Diseases and Immunology

PHONEBOOK

Infectious Diseases and Immunology

Director
Barbara Papadopoulou
Address
2705, boulevard Laurier, RC-709
Québec (Québec)
CANADA G1V 4G2
Phone
+1 418-654-2705
Fax
+1 418-654-2715

No active offer

All active job offers

No active study

All active clinical studies

Infectious Diseases and immunology is another key field at CRCHUQ. Researchers conduct basic as well as clinical and applied research on the mechanisms underpinning the onset and development of microbial infections and the resulting immune response. The ultimate goal is to achieve more effective control of infectious diseases and improved understanding of cellular and molecular immune and inflammation mechanisms involved in inflammation diseases and antimicrobial host defenses. Another is to develop new, rapid diagnostic tests and preventive and therapeutic treatments for infectious, inflammatory, and rheumatismal diseases. One research unit is also studying the development of immunological tolerance to organ and cell grafts. 

The main goal of this group’s research is to promote the transfer of biomedical knowledge to clinical practice. Researchers use cutting-edge technology such as DNA and protein biochips, microfluids and nanotechnology, bioinformatics, mass spectrometry, and real-time confocal microscopy.

Active research projects (see all research project in this area)

Chaire de Recherche du Canada. Laboratoire de Recherches physiopathologiques sur la mort cellulaire dans les interactions Hôtes/Pathogènes : Approches fondamentales et thérapeutiques
Jérome Estaquier
The Role of Fatty Acid Composition in Disease Activity And Cardiovascular Disease in Systemic Lupus Erythematosus.
Paul R. Fortin
Empowering Patients as Active Partners in Their Care: Lupus Interactive Navigator (LIN).
Paul R. Fortin
Étude des mécanismes d'action des plaquettes et microparticules de plaquettes dans l'arthrite inflammatoire
Eric Boilard
Identification of biomarkers in inflammatory chronic diseases
Marc Pouliot
Neutrophil activation pathways
Marc Pouliot
Identification de biomarqueurs dans les maladies chroniques
Marc Pouliot
Voies d'activation du neutrophile
Marc Pouliot
Contribution des phospholipase A2 au système immunitaire
Eric Boilard
Transcriptome and proteome analyses to study host susceptibility to human immunodefiency virus type 1 infection using primary human cells and human lymphoid tissues cultured ex vivo.
Michel G. Bergeron

Recent publications (see all publications in this area)

Skowronski D, De Serres G, Janjua N, Gardy J, Gilca V, Dionne M, Hamelin M, Rheaume C, Boivin G. Cross-reactive antibody to swine influenza A(H3N2) subtype virus in children and adults before and after immunisation with 2010/11 trivalent inactivated influenza vaccine in Canada, August to November 2010. Euro surveillance : bulletin europeen sur les maladies transmissibles = European communicable disease bulletin,  2012. 17: 
Routy J, Tremblay C, Angel J, Trottier B, Rouleau D, Baril J, Harris M, Trottier S, Singer J, Chomont N, Sekaly R, Boulassel M. Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical study. HIV medicine,  2012. Epub
Plourde M, Coelho A, Keynan Y, Larios OE, Ndao M, Ruest A, Roy G, Rubinstein E, Ouellette M. Genetic Polymorphisms and Drug Susceptibility in Four Isolates of Leishmania tropica Obtained from Canadian Soldiers Returning from Afghanistan. PLoS neglected tropical diseases,  2012. 6: e1463
Papenburg J, Carbonneau J, Hamelin ME, Isabel S, Bouhy X, Ohoumanne N, Dery P, Paes BA, Corbeil J, Bergeron MG, De Serres G, Boivin G. Molecular evolution of respiratory syncytial virus fusion gene, Canada, 2006-2010. Emerging infectious diseases,  2012. 18: 120-4
Nolin MA, Dumontier M, Belleau F, Corbeil J. Building an HIV data mashup using Bio2RDF. Briefings in bioinformatics,  2012. 13: 98-106
Bertin J, Barat C, Methot S, Tremblay MJ. Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system. Retrovirology,  2012. Epub
St-Pierre C, Ouellet M, Giguere D, Ohtake R, Roy R, Sato S, Tremblay MJ. Galectin-1-Specific Inhibitors as a New Class of Compounds To Treat HIV-1 Infection. Antimicrobial agents and chemotherapy,  2012. 56: 154-62
Boivin G, Goyette N, Farhan M, Ives J, Elston R. Incidence of cytomegalovirus UL97 and UL54 amino acid substitutions detected after 100 or 200 days of valganciclovir prophylaxis. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,  2012. Epub
Varin T, Lovejoy C, Jungblut AD, Vincent WF, Corbeil J. Metagenomic analysis of stress genes in microbial mat communities from antarctica and the high arctic. Applied and environmental microbiology,  2012. 78: 549-59
Ann J, Papenburg J, Bouhy X, Rheaume C, Hamelin ME, Boivin G. Molecular and antigenic evolution of human influenza A/H3N2 viruses in Quebec, Canada, 2009-2011. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,  2012. 53: 88-92
© 2012 All rights reserved CRCHUQ
<-->